DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/lxswnx/adult_malignant) has announced the addition of the "Adult Malignant Glioma -Pipeline Insights" report to their offering.
Adult Malignant Glioma - Pipeline Insights provides the in-depth analysis of the pipeline assets across the Adult Malignant Glioma . The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Adult Malignant Glioma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.
Adult Malignant Glioma - Pipeline Insights Report covers the Adult Malignant Glioma pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Adult Malignant Glioma related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Adult Malignant Glioma .
- The report provides a Adult Malignant Glioma Landscape across the globe
- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
- Coverage of the Adult Malignant Glioma pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Adult Malignant Glioma and also provide company profiling
- Pipeline products coverage based on various stages of development from NDA filings to discovery.
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
For more information visit http://www.researchandmarkets.com/research/lxswnx/adult_malignant